Ligand stabilization and effect on unfolding by polymorphism in human flavin-containing monooxygenase 3
- 1 November 2020
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 162, 1484-1493
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Identification of human flavin-containing monooxygenase 3 substrates by a colorimetric screening assayAnalytical Biochemistry, 2017
- Chemical applications of Class B flavoprotein monooxygenasesRendiconti Lincei. Scienze Fisiche e Naturali, 2016
- Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human liversDrug Metabolism and Pharmacokinetics, 2015
- Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activitiesBiochemical Pharmacology, 2013
- Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesDrug Metabolism and Disposition, 2007
- The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary AminesDrug Metabolism Reviews, 2006
- Some distinctions between flavin-containing and cytochrome P450 monooxygenasesBiochemical and Biophysical Research Communications, 2005
- Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolismPharmacology & Therapeutics, 2005
- The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and developmentDrug Discovery Today, 2004
- The molecular biology of the flavin-containing monooxygenases of manChemico-Biological Interactions, 1995